Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2021 / Cilt: 27 - Sayı: 4

Cytotoxic and Apoptotic Eff ects of Curcumin on D-17 Canine Osteosarcoma Cell Line

Kurkuminin D-17 Köpek Osteosarkom Hücre Hattı Üzerindeki Sitotoksik ve Apoptotik Etkileri

Pages
465–473
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, theseresults may provide a basis for further study of curcumin in the treatment of canine osteosarcoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cancer is a major health problem in dogs.
📊
Key Findings & Data:It constitutes 85% of skeletal tumors.
💡
Conclusion & Impact:Thus, theseresults may provide a basis for further study of curcumin in the treatment of canine osteosarcoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cancer is a major health problem in dogs. Types of cancer seen in dogs include melanoma, Non-Hodgkin lymphoma, osteosarcoma, soft tissuesarcomas and prostate, breast, lung and colorectal carcinomas. Osteosarcoma (OSA) is the most common malignant primary bone tumor indomestic dogs. It constitutes 85% of skeletal tumors. It is derived from primitive bone cells that occur in both the appendicular (~75%) andaxial (~25%) skeleton. The present study was intended to determine the cytotoxic and apoptotic eff ects of curcumin administration at certaindoses and in certain periods on D-17 canine osteosarcoma cells. Canine osteosarcoma cells were treated with curcumin and the eff ects ofit on proliferation were determined by WST-1, apoptosis by caspase 3/7 activity (MuseCaspase 3/7) and the ratio of proapoptotic Bax geneto antiapoptotic Bcl-2 gene expression level by qRT-PCR. Our data demonstrated that curcumin decreased cell proliferation and viability,ultimately inducing caspase 3/7 mediated apoptosis in treated D-17 canine osteosarcoma cells. Furthermore, the application of curcuminon canine osteosarcoma cells downregulated the expression of Bcl-2 and upregulated the expression of proapoptotic gene Bax. Thus, theseresults may provide a basis for further study of curcumin in the treatment of canine osteosarcoma.

Özet

Kanser, köpeklerde büyük bir sağlık sorunudur. Köpeklerde görülen kanser türleri arasında melanom, Non-Hodgkin lenfoma, osteosarkom, yumuşak doku sarkomları ve prostat, meme, akciğer ve kolorektal karsinomlar bulunur. Osteosarkom (OSA) evcil köpeklerde en sık görülen kötü huylu birincil kemik tümörüdür. İskelet tümörlerinin %85’ini oluşturur. Hem apendiküler (~%75) hem de aksiyal (~%25) iskelette meydana gelen ilkel kemik hücrelerinden türemektedir. Bu çalışmanın amacı, belirli dozlarda ve belirli periyotlarda kurkumin uygulamasının ardından D-17 köpek osteosarkom hücreleri üzerindeki sitotoksik ve apoptotik etkilerini saptamaktır. Kurkumin uygulanan köpek osteosarkom hücrelerinde proliferasyon üzerindeki etkileri WST-1 analiziyle, apoptotik etkileri ise kaspaz 3/7 aktivitesi (MuseCaspase 3/7) ve proapoptotik Bax geninin antiapoptotik Bcl-2 gen ekspresyon düzeyine oranı ile belirlendi. Verilerimiz kurkuminin D-17 köpek osteosarkom hücrelerinde hücre proliferasyonunu ve canlılığını azalttığını, kazpaz 3/7 aracılığıyla apoptozu indüklediğini göstermektedir. Bunun yanında kurkuminin köpek osteosarkom hücrelerine uygulanması Bcl-2’nin ekspresyonunu azalttı ve proapoptotik gen Bax ekspresyonunu arttırdı. Bu nedenle, bu sonuçlar, köpek osteosarkoma tedavisinde kurkumin ile ilgili daha fazla çalışma için bir temel sağlayabilir.

🔖

Cite This Article

BİLDİK, A., BAYAR, İ., AŞICI, G. S. E., KIRAL, F., ULUTAŞ, P. A. (2022). Cytotoxic and Apoptotic Eff ects of Curcumin on D-17 Canine Osteosarcoma Cell Line. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 27 - Sayı: 4, 465–473. https://ajindex.com/articles/569540

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Makielski KM, Mills LJ, Sarver AL, Henson MS, Spector LG, Naik S, Modiano JF: Risk factors for development of canine and human osteosarcoma: A comparative review. Vet Sci, 6 (2): 48, 2019. DOI: 10.3390/ vetsci6020048 2. Ulutaş PA, Kıral F, Ulutaş B, Aşıcı GSE: Cytotoxic and apoptotic effect of nanoclinoptilolite on canine osteosarcoma cell lines. J Vet Res, 64 (4): 589-596, 2020. DOI: 10.2478/jvetres-2020-0063 3. Jun W, Peng C, Wen J, Mingzhi G: Experimental study on curcumin inhibiting proliferation and invasion of human osteosarcoma cells. Biomed Res, 28 (10): 4396-4401, 2017. 4. Krajarng A, Nilwarankoon S, Suksamrarn S, Watanapokasin R: Antiproliferative effect of α-mangostin on canine osteosarcoma cells. Res Vet Sci, 93, 788-794, 2012. DOI: 10.1016/j.rvsc.2012.01.015 5. Wilson-Robles H, Franks K, Pool R, Miller T: Characterization of five newly derived canine osteosarcoma cell lines. BMC Vet Res, 15:357, 2019. DOI: 10.1186/s12917-019-2099-y 6. Anfinsen KP, Grotmol T, Bruland OS, Jonasdottir TJ: Breed-specific incidence rates of canine primary bone tumors-A population based survey of dogs in Norway. Can J Vet Res, 75, 209-215, 2011. 7. Gebhard C, Miller I, Hummel K, Ondrovics MN, Schlosser S, Walter I: Comparative proteome analysis of monolayer and spheroid culture of canine osteosarcoma cells. J Proteomics, 177, 124-136, 2018. DOI: 10.1016/j.jprot.2018.01.006 8. Simpson S, Dunning M, de Brot S, Alibhai A, Bailey C, Woodcock CL, Mestas M, Akhtar S, Jeyapalan JN, Lothion-Roy J, Emes RD, Allegrucci C, Rizvanov AA, Mongan NP, Rutland CS: Molecular characterisation of canine osteosarcoma in high risk breeds. Cancers, 12 (9): 2405, 2020. DOI: 10.3390/cancers12092405 9. Selvarajah GT, Kirpensteijn J: Prognostic and predictive biomarkers of canine osteosarcoma. Vet J, 185 (1): 28-35, 2010. DOI: 10.1016/j. tvjl.2010.04.010 10. Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS: Comparative review of human and canine osteosarcoma: Morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand, 59 (1): 71, 2017. DOI: 10.1186/s13028-017-0341-9 11. Wolfesberger B, Tonar Z, Gerner W, Skalicky M, Heiduschka G, Egerbacher M, Thalhammer JG, Walter I: The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line. Res Vet Sci, 88 (1): 94-100, 2010. DOI: 10.1016/j. rvsc.2009.06.009 12. Szewczyk M, Lechowski R, Zabielska K: What do we know about canine osteosarcoma treatment? - Revie